Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Direvo Reaches Milestone in Consolidated Bioprocessing of Lignocellulose to Lactic Acid

Published: Tuesday, March 12, 2013
Last Updated: Tuesday, March 12, 2013
Bookmark and Share
Company ferments lactic acid on pilot scale in a single-step-synthesis.

Direvo Industrial Biotechnology GmbH (Direvo) has announced that it has reached an important milestone in developing a consolidated bioprocess for lactic acid production from lignocellulose.

Up until now, there has not been any known consolidated bioprocess for producing lactic acid from lignocellulose.

Direvo has now successfully built up a processing chain from pretreatment through fermentation to downstream processing for a consolidated bioprocess for lactic acid.

On the basis of pretreated Miscanthus grass, Direvo fermented lactic acid on pilot scale in a single-step-synthesis.

Direvo was further able to show that the important step of downstream processing of free lactic acid in the fermentation matrix can be realized efficiently by standardized procedures.

The downstream processing was executed in collaboration with the department of bioengineering of the Leibniz Institute for Agricultural Engineering Potsdam-Bornim.

Direvo’s specific, self-isolated proprietary microorganism Caldicellulosiruptor sp. produces the needed enzymes to ferment the pretreated biomass and converts the emerging sugar to end products.

In these processes, no cost-intensive technical enzymes have to be added.

A further advantage is that these microorganisms are extreme thermophile and therefore high process temperatures don’t cause product losses through contamination with foreign bacteria.

On the basis of this proof-of-concept, the next development stage to raise competitiveness in a commercial environment will be to increase the yield of lactic acid.

Consolidated bioprocessing is the conversion of lignocellulose into target products in a single step without having to add enzymes.

Direvo develops consolidated bioprocesses for production of biofuels and biobased chemicals under the brand name BluCon®.

Beside Lactic Acid, BluCon®-L, Direvo pursues with Ethanol, BluCon®-E, another product line.

BluCon® converts various non-food biomass ranging from grasses and straw to agricultural and wood residues and can therefore be applied around the globe.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
Crouching Protein, Hidden Enzyme
A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.
Utilizing Antibodies from Ebola Survivors
A collaborative team from The University of Texas Medical Branch at Galveston, Vanderbilt University, The Scripps Research Institute and Integral Molecular Inc. have learned that antibodies in the blood of people who have survived a strain of the Ebola virus can kill various types of Ebola.
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
Important Regulator of Immune System Decoded
Plasma cells play a key role in our immune system. Now scientists at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria, and at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, succeeded in characterizing a central regulator of plasma cell function.
Bacterial Superglue for Faster Vaccine Development
An interdisciplinary team of Oxford University researchers has devised a new technique to speed up the development of novel vaccines.
Enumeral, MD Anderson Enter Into Collaboration
Strategic collaboration aims to discover and develop potentially novel antibodies against specified targets for immunotherapy.
Joint venture for GlycoMar Limited and MicroA AS
Scottish biotechnology company GlycoMar and Norwegian technology company MicroA are pleased to announce their joint venture business Prasinotech Ltd. The new company is registered in Scotland.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!